Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

The Number of Donor-Specific IL-21 Producing Cells Before and After Transplantation Predicts Kidney Graft Rejection.

van Besouw NM, Yan L, de Kuiper R, Klepper M, Reijerkerk D, Dieterich M, Roelen DL, Claas FHJ, Clahsen-van Groningen MC, Hesselink DA, Baan CC.

Front Immunol. 2019 Apr 9;10:748. doi: 10.3389/fimmu.2019.00748. eCollection 2019.

2.

Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile.

Wu Y, Hoogduijn MJ, Baan CC, Korevaar SS, de Kuiper R, Yan L, Wang L, van Besouw NM.

Stem Cells Int. 2017;2017:4960831. doi: 10.1155/2017/4960831. Epub 2017 May 31.

3.

Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.

Kho MM, Zuijderwijk JM, van der Eijk AA, de Kuiper R, Boer-Verschragen MJ, Weimar W, van Besouw NM.

Vaccine. 2017 Jan 3;35(1):71-76. doi: 10.1016/j.vaccine.2016.11.043. Epub 2016 Nov 26.

PMID:
27899225
4.

Herpes zoster after lung transplantation boosts varicella zoster virus-specific adaptive immune responses.

van Besouw NM, van Hal PT, Zuijderwijk JM, de Kuiper R, Hoek RA, van Weezel JJ, van der Eijk AA, Verjans GM, Weimar W.

J Heart Lung Transplant. 2016 Dec;35(12):1435-1442. doi: 10.1016/j.healun.2016.04.009. Epub 2016 May 6.

PMID:
27293105
5.

An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss.

Reus AD, van Besouw NM, Molenaar NM, Steegers EA, Visser W, de Kuiper RP, de Krijger RR, Roelen DL, Exalto N.

Am J Reprod Immunol. 2013 Sep;70(3):230-7. doi: 10.1111/aji.12125. Epub 2013 Apr 24.

PMID:
23611029
6.

Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells.

Crop MJ, Korevaar SS, de Kuiper R, IJzermans JN, van Besouw NM, Baan CC, Weimar W, Hoogduijn MJ.

Cell Transplant. 2011;20(10):1547-59. doi: 10.3727/096368910X564076. Epub 2011 Mar 7.

PMID:
21396164
7.

Preeclampsia is associated with increased cytotoxic T-cell capacity to paternal antigens.

de Groot CJ, van der Mast BJ, Visser W, De Kuiper P, Weimar W, Van Besouw NM.

Am J Obstet Gynecol. 2010 Nov;203(5):496.e1-6. doi: 10.1016/j.ajog.2010.06.047. Epub 2010 Aug 17.

PMID:
20723874
8.

Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.

van de Wetering J, Koumoutsakos P, Peeters A, van der Mast BJ, de Kuiper P, IJzermans JN, Weimar W, Baan CC.

Clin Transplant. 2011 Jan-Feb;25(1):40-6. doi: 10.1111/j.1399-0012.2010.01311.x.

PMID:
20636406
9.

Deficient TNF-alpha and IFN-gamma production correlates with nondetectable donor-specific cytotoxicity after clinical kidney transplantation.

van Besouw NM, de Kuiper R, van der Mast BJ, van de Wetering J, Baan CC, Weimar W.

Transplantation. 2009 May 27;87(10):1451-4. doi: 10.1097/TP.0b013e3181a36c85.

PMID:
19461480
10.

Donor-specific immune regulation by CD8 lymphocytes expanded from rejecting human cardiac allografts.

Dijke IE, Caliskan K, Klepper M, de Kuiper R, Balk AH, Maat AP, Weimar W, Baan CC.

Am J Transplant. 2009 Feb;9(2):397-403. doi: 10.1111/j.1600-6143.2008.02498.x. Epub 2008 Dec 15.

11.

After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity.

van Besouw NM, van de Wetering J, van der Mast BJ, de Kuiper R, Baan CC, Weimar W.

Clin Transplant. 2008 Mar-Apr;22(2):129-35. doi: 10.1111/j.1399-0012.2007.00754.x.

PMID:
18339130
12.

Interleukin-21: an interleukin-2 dependent player in rejection processes.

Baan CC, Balk AH, Dijke IE, Korevaar SS, Peeters AM, de Kuiper RP, Klepper M, Zondervan PE, Maat LA, Weimar W.

Transplantation. 2007 Jun 15;83(11):1485-92.

PMID:
17565322
13.

FoxP3+ T cells can be expanded from rejecting cardiac allografts.

Dijke E, Velthuis J, Balk A, de Kuiper R, Klepper M, Caliskan K, Weimar W, Baan C.

Transplant Proc. 2006 Dec;38(10):3233-5.

PMID:
17175232
14.

Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency.

van der Mast BJ, Rischen-Vos J, de Kuiper P, Vaessen LM, van Besouw NM, Weimar W.

Transplantation. 2005 Nov 15;80(9):1220-5.

PMID:
16314789
15.

The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation.

van Besouw NM, Zuijderwijk JM, de Kuiper P, Ijzermans JN, Weimar W, van der Mast BJ.

Transplantation. 2005 May 15;79(9):1062-6.

PMID:
15880044
16.

Reduction of immunosuppressive load in renal transplant recipients with a low donor-specific cytotoxic T-lymphocyte precursor frequency is safe.

van de Wetering J, van der Mast BJ, de Kuiper P, van Besouw NM, Rischen-Vos J, Ijzermans JN, Weimar W.

Transplant Proc. 2005 Mar;37(2):779-81.

PMID:
15848529
17.

Tapering immunosuppression in recipients of living donor kidney transplants.

Weimar W, Rischen-Vos J, de Kuiper P, Gregoor PJ, IJzermans JN, van Besouw NM, Baan CC, van der Mast BJ.

Nephrol Dial Transplant. 2004 Jul;19 Suppl 4:iv61-3.

PMID:
15240852
18.

Formation of donor-specific human leukocyte antigen antibodies after kidney transplantation: correlation with acute rejection and tapering of immunosuppression.

van der Mast BJ, van Besouw NM, Witvliet MD, de Kuiper P, Smak Gregoor P, van Gelder T, Weimar W, Claas FH.

Transplantation. 2003 Mar 27;75(6):871-7.

PMID:
12660517
19.

Down-regulated donor-specific T-cell reactivity during successful tapering of immunosuppression after kidney transplantation.

van Besouw NM, van der Mast BJ, de Kuiper P, Smak regoor PJ, Vaessen LM, Ijzermans JN, van Gelder T, Weimar W.

Clin Exp Immunol. 2002 May;128(2):388-93.

20.

Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.

van der Mast BJ, van Besouw NM, de Kuiper P, Vaessen LM, Gregoor PJ, IJzermans JN, van Gelder T, Claas FH, Weimar W.

Transplantation. 2001 Sep 15;72(5):873-80.

PMID:
11571453

Supplemental Content

Loading ...
Support Center